Test Price
3,000 AED✅ Home Collection Available
NGSNeuro NGS Genetic Test for Neurological Disorders – DHA Licensed Lab | AED 3,000
Executive Summary & Core Metrics
Guaranteed Clinical Confidence
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS pipeline (Cert: INT/EGQ/2509DA/3139).
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection by DHA-licensed phlebotomists (8 AM – 11 PM).
- Post-Test Telephonic Clinical Guidance with a consultant medical geneticist to interpret results and plan next steps.
- Direct Insurance Billing Verification: send your Emirates ID via WhatsApp to +971 54 548 8731.
Clinical Utility
This panel delivers targeted analysis of over 200 genes associated with hereditary neurological disorders, providing actionable insights for early diagnosis and management.
Test Overview & Methodology
The NGSNeuro Genetic Test is a next-generation sequencing panel that simultaneously analyzes over 200 genes linked to hereditary neurological disorders including ataxias, neuropathies, epileptic encephalopathies, and early-onset dementias. The assay uses Illumina-based NGS with a custom neurological capture baitset, followed by orthogonal Sanger confirmation for all clinically reported variants.
| Feature | Our NGSNeuro NGS Panel | Whole Exome Sequencing (WES) |
|---|---|---|
| Diagnostic Precision | Targeted coverage of >200 neuro‑specific genes with deep read depth | Genome‑wide but shallower coverage; higher incidental findings rate |
| Methodology | Illumina®‑based NGS with custom neurological capture; verified by Sanger | Standard exome capture and broad bioinformatics pipeline |
| Turnaround Time | 3–4 weeks from sample receipt | 6–12 weeks, often with backlogs |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that this NGS panel provides crucial insights into hereditary neurological conditions. However, genetic results must always be interpreted in the context of family history and clinical presentation. I strongly recommend the post-test genetic counselling session included with this panel to fully understand implications and discuss any necessary follow-up steps.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not stop, alter, or reduce any prescribed medication based on the results of this genetic test without explicit instruction from your treating physician. This test is a diagnostic aid, not a replacement for clinical management. Always consult your neurologist or genetic counsellor before making any treatment decisions.
Patient Exclusion Criteria & Emergency Red Flags
- Patients under 18 years of age without notarized parental/guardian consent.
- Individuals unable to provide a complete three‑generation pedigree or who lack the capacity to give informed consent.
- Acute psychiatric crisis rendering the patient incapable of understanding test implications.
- Seek immediate emergency care at the nearest hospital if you experience: sudden paralysis, unrelenting seizure, acute confusion, or loss of consciousness — before proceeding with this elective genetic test.
Patient FAQ & Clinical Guidance
1. What exactly does the NGSNeuro NGS panel detect?
This advanced genetic test analyzes over 200 genes linked to hereditary neurological conditions with 99.9% diagnostic accuracy, identifying pathogenic variants for disorders such as hereditary ataxias, early‑onset Parkinson’s, epileptic encephalopathies, and mitochondrial neuropathies. Every reported variant is interpreted by a board‑certified clinical geneticist.
2. How should I prepare, and what sample is needed?
You must attend a mandatory genetic counselling session to draw a 3‑generation pedigree, obtain informed consent, and select the optimal sample type. Acceptable specimens include a standard venous blood draw (EDTA tube), a painless dried blood spot on an FTA card, or previously extracted DNA. No dietary or medication restrictions are required, but please continue all prescribed treatments unless your doctor advises otherwise.
3. Is this test covered by insurance in the UAE?
Many UAE insurers now reimburse NGS‑based neurological panels when a qualified neurologist or clinical geneticist prescribes and provides a detailed medical justification, especially for patients with early‑onset symptoms or a strong family history. Our dedicated team verifies your coverage in real time via WhatsApp (+971 54 548 8731) before sample collection, so you know your exact financial responsibility.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled with the highest privacy and security standards, in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Federal Decree-Law No. 4 of 2016 on Medical Liability for clinical safety and patient consent.
Clinical & Logistical Metadata
| Test Name | NGSNeuro NGS Genetic Test for Neurological Disorders |
| Price (AED) | 3,000 |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Whole blood (EDTA), Dried blood spot (FTA card), or extracted DNA |
| Methodology Used | Illumina-based NGS with custom neurological capture; Sanger confirmation |
| ICD-10-CM Code | Z13.78 |
| LOINC Code | 81314-6 |
| DHA Facility License & Laboratory Address | License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians